Skip to main content
Erschienen in: International Journal of Hematology 4/2014

01.04.2014 | Case Report

Successful transcatheter aortic valve implantation in a Hodgkin lymphoma patient with severe aortic stenosis

verfasst von: Cenk Sari, Tahir Durmaz, Abdullah Nabi Aslan, Telat Keleş, Murat Akçay, Nihal Akar Bayram, Hüseyin Ayhan, Emine Bilen, Serdal Baştuğ, Hacı Ahmet Kasapkara, Mehmet Burak Özen, Ömer Faruk Çiçek, Engin Bozkurt

Erschienen in: International Journal of Hematology | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Transcatheter aortic valve implantation (TAVI) has emerged as an acceptable treatment modality for patients with severe aortic stenosis (AS) who are deemed unsuitable for conventional surgical aortic valve replacement. TAVI not only provides the treatment of AS, but also makes some other diseases treatable by relieving hemodynamic distress resulting from AS. In this case report, we presented a 74-year-old patient with Hodgkin’s lymphoma (HL) that had been left untreated due to the development of acute pulmonary edema caused by severe degenerative AS during chemotherapy. This is the first report of the use of TAVI in a patient with HL.
Literatur
1.
Zurück zum Zitat Ben-Dor I, Pichard AD, Gonzalez MA, et al. Correlates and causes of death in patients with severe symptomatic aortic stenosis who are not eligible to participate in a clinical trial of transcatheter aortic valve implantation. Circulation. 2010;122:S37–42.PubMedCrossRef Ben-Dor I, Pichard AD, Gonzalez MA, et al. Correlates and causes of death in patients with severe symptomatic aortic stenosis who are not eligible to participate in a clinical trial of transcatheter aortic valve implantation. Circulation. 2010;122:S37–42.PubMedCrossRef
2.
Zurück zum Zitat Turina J, Hess O, Sepulcri F, et al. Spontaneous course of aortic valve disease. Eur Heart J. 1987;8:471–83.PubMed Turina J, Hess O, Sepulcri F, et al. Spontaneous course of aortic valve disease. Eur Heart J. 1987;8:471–83.PubMed
3.
Zurück zum Zitat Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607.PubMedCrossRef Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607.PubMedCrossRef
4.
Zurück zum Zitat Lindblom D, Lindblom U, Qvist J, et al. Long-term relative survival rates after heart valve replacement. J Am Coll Cardiol. 1990;15:566–73.PubMedCrossRef Lindblom D, Lindblom U, Qvist J, et al. Long-term relative survival rates after heart valve replacement. J Am Coll Cardiol. 1990;15:566–73.PubMedCrossRef
5.
Zurück zum Zitat Charlson E, Legedza AT, Hamel MB. Decision-making and outcomes in severe symptomatic aortic stenosis. J Heart Valve Dis. 2006;15:312–21.PubMed Charlson E, Legedza AT, Hamel MB. Decision-making and outcomes in severe symptomatic aortic stenosis. J Heart Valve Dis. 2006;15:312–21.PubMed
6.
Zurück zum Zitat Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106:3006–8.PubMedCrossRef Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106:3006–8.PubMedCrossRef
7.
Zurück zum Zitat Cribier A. Development of transcatheter aortic valve implantation (TAVI): a 20-year odyssey. Arch Cardiovasc Dis. 2012;105:146–52.PubMedCrossRef Cribier A. Development of transcatheter aortic valve implantation (TAVI): a 20-year odyssey. Arch Cardiovasc Dis. 2012;105:146–52.PubMedCrossRef
8.
Zurück zum Zitat Townsend CM, et al. Sabiston textbook of surgery. 18th ed. Philadelphia: Saunders; 2008. p. 1841–4. Townsend CM, et al. Sabiston textbook of surgery. 18th ed. Philadelphia: Saunders; 2008. p. 1841–4.
9.
Zurück zum Zitat Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, et al. Guidelines on the management of valvular heart disease (version 2012): the joint task force on the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2012;33(19):2451–96.PubMedCrossRef Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, et al. Guidelines on the management of valvular heart disease (version 2012): the joint task force on the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2012;33(19):2451–96.PubMedCrossRef
10.
Zurück zum Zitat Iung B, Cachier A, Baron G, et al. Decision making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J. 2005;26:2714–20.PubMedCrossRef Iung B, Cachier A, Baron G, et al. Decision making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J. 2005;26:2714–20.PubMedCrossRef
11.
Zurück zum Zitat Brenner H, Gondos A, Pulte D. Ongoing improvement in long-term survival of patients with Hodgkin disease at all ages and recent catch-up of older patients. Blood. 2008;111(6):2977–83.PubMedCrossRef Brenner H, Gondos A, Pulte D. Ongoing improvement in long-term survival of patients with Hodgkin disease at all ages and recent catch-up of older patients. Blood. 2008;111(6):2977–83.PubMedCrossRef
Metadaten
Titel
Successful transcatheter aortic valve implantation in a Hodgkin lymphoma patient with severe aortic stenosis
verfasst von
Cenk Sari
Tahir Durmaz
Abdullah Nabi Aslan
Telat Keleş
Murat Akçay
Nihal Akar Bayram
Hüseyin Ayhan
Emine Bilen
Serdal Baştuğ
Hacı Ahmet Kasapkara
Mehmet Burak Özen
Ömer Faruk Çiçek
Engin Bozkurt
Publikationsdatum
01.04.2014
Verlag
Springer Japan
Erschienen in
International Journal of Hematology / Ausgabe 4/2014
Print ISSN: 0925-5710
Elektronische ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-014-1500-7

Weitere Artikel der Ausgabe 4/2014

International Journal of Hematology 4/2014 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.